Amphastar Pharmaceuticals (AMPH) EBITDA Margin Growth (5y) (2018 - 2026)
Amphastar Pharmaceuticals (AMPH) EBITDA Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Amphastar Pharmaceuticals | 936.60 Mn | 646.48 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,122.00 |
| Mar 31, 2026 | -204.00 |
| Dec 31, 2025 | 1,644.00 |
| Sep 30, 2025 | 898.00 |
| Jun 30, 2025 | 2,759.00 |
| Mar 31, 2025 | 1,304.00 |
| Dec 31, 2024 | 2,450.00 |
| Sep 30, 2024 | 2,683.00 |
| Jun 30, 2024 | 2,904.00 |
| Mar 31, 2024 | 3,191.00 |
| Dec 31, 2023 | 2,859.00 |
| Sep 30, 2023 | 3,688.00 |
| Jun 30, 2023 | 2,946.00 |
| Mar 31, 2023 | 4,062.00 |
| Dec 31, 2022 | 3,091.00 |
| Sep 30, 2022 | 2,442.00 |
| Jun 30, 2022 | 1,675.00 |
| Mar 31, 2022 | 1,548.00 |
| Dec 31, 2021 | 2,766.00 |
| Sep 30, 2021 | 1,305.00 |